Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D

One of the most promising therapeutic approaches for numerous hematological malignancies represents the allogeneic hematopoietic stem cell transplantation (allo-HSCT). One major complication is the development of the life-threatening graft-vs.-host disease (GvHD) which limits beneficial effects of g...

Full description

Bibliographic Details
Main Authors: Cindy Flamann, Katrin Peter, Marina Kreutz, Heiko Bruns
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02586/full
_version_ 1818160181779890176
author Cindy Flamann
Katrin Peter
Marina Kreutz
Heiko Bruns
author_facet Cindy Flamann
Katrin Peter
Marina Kreutz
Heiko Bruns
author_sort Cindy Flamann
collection DOAJ
description One of the most promising therapeutic approaches for numerous hematological malignancies represents the allogeneic hematopoietic stem cell transplantation (allo-HSCT). One major complication is the development of the life-threatening graft-vs.-host disease (GvHD) which limits beneficial effects of graft-vs.-leukemia (GvL) responses during allo-HSCT. Strengthening GvL effects without induction of severe GvHD is essential to decrease the relapse rate after allo-HSCT. An interesting player in this context is vitamin D3 since it has modulatory capacity in both preventing GvHD and boosting GvL responses. Current studies claim that vitamin D3 induces an immunosuppressive environment by dendritic cell (DC)-dependent generation of regulatory T cells (Tregs). Since vitamin D3 is known to support the antimicrobial defense by re-establishing the physical barrier as well as releasing defensins and antimicrobial peptides, it might also improve graft-vs.-infection (GvI) effects in patients. Beyond that, alloreactive T cells might be attenuated by vitamin D3-mediated inhibition of proliferation and activation. Despite the inhibitory effects of vitamin D3 on T cells, anti-tumor responses of GvL might be reinforced by vitamin D3-triggered phagocytic activity and antibody-based immunotherapy. Therefore, vitamin D3 treatment does not only lead to a shift from a pro-inflammatory toward a tolerogenic state but also promotes tumoricidal activity of immune cells. In this review we focus on vitamin D3 and its immunomodulatory effects by enhancing anti-tumor activity while alleviating harmful allogeneic responses in order to restore the immune balance.
first_indexed 2024-12-11T15:57:48Z
format Article
id doaj.art-b493a211640943ba81076053e2332b48
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T15:57:48Z
publishDate 2019-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b493a211640943ba81076053e2332b482022-12-22T00:59:23ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-11-011010.3389/fimmu.2019.02586481593Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin DCindy Flamann0Katrin Peter1Marina Kreutz2Heiko Bruns3Department of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen–Nuremberg, Erlangen, GermanyDepartment of Internal Medicine III – Hematology and Internal Oncology, University Hospital of Regensburg, Regensburg, GermanyDepartment of Internal Medicine III – Hematology and Internal Oncology, University Hospital of Regensburg, Regensburg, GermanyDepartment of Internal Medicine 5, Hematology/Oncology, Friedrich Alexander University Erlangen–Nuremberg, Erlangen, GermanyOne of the most promising therapeutic approaches for numerous hematological malignancies represents the allogeneic hematopoietic stem cell transplantation (allo-HSCT). One major complication is the development of the life-threatening graft-vs.-host disease (GvHD) which limits beneficial effects of graft-vs.-leukemia (GvL) responses during allo-HSCT. Strengthening GvL effects without induction of severe GvHD is essential to decrease the relapse rate after allo-HSCT. An interesting player in this context is vitamin D3 since it has modulatory capacity in both preventing GvHD and boosting GvL responses. Current studies claim that vitamin D3 induces an immunosuppressive environment by dendritic cell (DC)-dependent generation of regulatory T cells (Tregs). Since vitamin D3 is known to support the antimicrobial defense by re-establishing the physical barrier as well as releasing defensins and antimicrobial peptides, it might also improve graft-vs.-infection (GvI) effects in patients. Beyond that, alloreactive T cells might be attenuated by vitamin D3-mediated inhibition of proliferation and activation. Despite the inhibitory effects of vitamin D3 on T cells, anti-tumor responses of GvL might be reinforced by vitamin D3-triggered phagocytic activity and antibody-based immunotherapy. Therefore, vitamin D3 treatment does not only lead to a shift from a pro-inflammatory toward a tolerogenic state but also promotes tumoricidal activity of immune cells. In this review we focus on vitamin D3 and its immunomodulatory effects by enhancing anti-tumor activity while alleviating harmful allogeneic responses in order to restore the immune balance.https://www.frontiersin.org/article/10.3389/fimmu.2019.02586/fullvitamin DGvHGvLimmune balancemacrophagesT cells
spellingShingle Cindy Flamann
Katrin Peter
Marina Kreutz
Heiko Bruns
Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
Frontiers in Immunology
vitamin D
GvH
GvL
immune balance
macrophages
T cells
title Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
title_full Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
title_fullStr Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
title_full_unstemmed Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
title_short Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
title_sort regulation of the immune balance during allogeneic hematopoietic stem cell transplantation by vitamin d
topic vitamin D
GvH
GvL
immune balance
macrophages
T cells
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02586/full
work_keys_str_mv AT cindyflamann regulationoftheimmunebalanceduringallogeneichematopoieticstemcelltransplantationbyvitamind
AT katrinpeter regulationoftheimmunebalanceduringallogeneichematopoieticstemcelltransplantationbyvitamind
AT marinakreutz regulationoftheimmunebalanceduringallogeneichematopoieticstemcelltransplantationbyvitamind
AT heikobruns regulationoftheimmunebalanceduringallogeneichematopoieticstemcelltransplantationbyvitamind